Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
170.3 USD | +2.45% | +3.55% | -21.53% |
Mar. 20 | US Equity Markets Close Higher Wednesday as Fed Holds Rates Steady | MT |
Mar. 20 | Insulet Names Ana Maria Chadwick Finance Chief | MT |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- Growth is a substantial asset for the company, as anticipated by dedicated analysts. Within the next three years, growth is estimated to reach 61% by 2026.
- Over the last twelve months, the sales forecast has been frequently revised upwards.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last 4 months, the company has been enjoying highly positive EPS revisions, which were frequently and significantly raised.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
- Consensus analysts have strongly revised their opinion of the company over the past 12 months.
- The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 57.82 and 45.18 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-21.53% | 11.92B | B- | ||
-2.54% | 186B | C+ | ||
-1.85% | 107B | C | ||
-4.26% | 67.44B | A | ||
+1.39% | 50.03B | B- | ||
+16.82% | 47.81B | B- | ||
+4.79% | 41.03B | B+ | ||
+3.49% | 26.85B | B | ||
+0.65% | 25.82B | A- | ||
+16.55% | 24.74B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PODD Stock
- Ratings Insulet Corporation